Form 4: Astrana Health Executive John Vong Reports Share Surrender for Tax Obligations
SEC Form 4 Filing
Chief Accounting Officer John Vong surrendered 336 shares of Astrana Health stock to cover tax obligations related to vesting restricted stock.
Summary
- On July 11, 2024, John Vong, Chief Accounting Officer of Astrana Health, Inc., surrendered 336 shares of common stock to cover tax withholding obligations.
- The transaction was executed at a price of $45 per share.
- Following the transaction, Vong beneficially owns 18,357 shares of Astrana Health, Inc.
- This total includes 13,983 shares of restricted stock that will vest over time, subject to continuous employment and, in some cases, achievement of performance goals.
- It also includes 76 shares acquired under the issuer's Employee Stock Purchase Plan.
Sentiment
Score: 6
Explanation: The document reflects a routine transaction related to executive compensation. It is neither particularly positive nor negative, but rather a standard disclosure.
Positives
- The reporting person participates in the Employee Stock Purchase Plan, indicating confidence in the company's future.
Future Outlook
The document does not contain specific forward-looking statements, but it outlines the vesting schedule for restricted stock, indicating future equity compensation for the reporting person.
Industry Context
Form 4 filings are routine disclosures required by the SEC to ensure transparency in insider trading activities. This filing indicates a common practice of executives surrendering shares to cover tax obligations related to equity compensation.
Comparison to Industry Standards
- Share surrenders for tax obligations are a common practice among executives in publicly traded companies.
- The vesting schedules outlined are typical for restricted stock grants, often tied to continued employment and performance metrics.
- Similar filings can be observed for executives at companies like UnitedHealth Group (UNH) and CVS Health (CVS), which also utilize equity compensation.
Stakeholder Impact
- The transaction has a minimal direct impact on shareholders, as it involves a small number of shares surrendered for tax purposes.
- Employees may be interested in the vesting schedules of restricted stock, as it provides insight into the company's compensation practices.
Key Dates
| Date | Description |
|---|---|
| 07/11/2024 | Date of the transaction (share surrender for tax obligations). |
| 07/12/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.